case study: progression on alk inhibitors in nsclc
Published 10 years ago • 485 plays • Length 6:04Download video MP4
Download video MP3
Similar videos
-
3:52
case study: met and alk targeted therapies in nsclc
-
5:18
utilizing next-generation alk inhibitors in nsclc
-
4:23
efficacy of next-generation alk inhibitors in nsclc
-
8:37
alk inhibition in nsclc
-
6:51
progression in alk nsclc after frontline therapy
-
8:04
treating with alk inhibitors in nsclc
-
6:27
alk inhibitor sequencing in nsclc
-
4:37
development of alk inhibitors in advanced non-small cell lung cancer
-
6:41
next-generation alk inhibitors for nsclc
-
8:17
third-generation alk inhibitors for nsclc
-
11:54
case based panel discussion 2.5 progression after alk inhibitors is there a role for combination the
-
8:35
next generation alk inhibitors for nsclc
-
8:36
case study: mutation-negative patient with lung adenocarcinoma
-
9:59
case based panel discussions - alk positive, developing resistance to alk inhibitors and next steps
-
1:07
case presentation: patient with alk nsclc
-
0:41
progression on an alk inhibitor - nsclc from asco
-
22:10
first and second generation alk inhibitors for the treatment of lung cancer
-
6:54
upfront use of next-generation alk inhibitors in nsclc
-
10:45
case based panel discussion 2.3 developing resistance to alk inhibitors, areas of progression after